CNAT - Conatus Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate-0.17-0.16-0.650.62
Low Estimate-0.26-0.16-0.73-0.89
High Estimate-0.12-0.16-0.62.24
Year Ago EPS-0.35-0.14-1.31-0.65
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate10.75M9.5M39.75M58.51M
Low Estimate9.5M9.5M36.07M32.75M
High Estimate13.75M9.5M50.01M116M
Year Ago Sales799k7M799k39.75M
Sales Growth (year/est)1,245.40%35.80%4,875.00%47.20%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.26-0.22-0.17-0.05
EPS Actual-0.35-0.14-0.19-0.13
Difference-0.090.08-0.02-0.08
Surprise %-34.60%36.40%-11.80%-160.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.17-0.16-0.650.62
7 Days Ago-0.17-0.16-0.650.62
30 Days Ago-0.17-0.16-0.650.62
60 Days Ago-0.15-0.47-0.530.7
90 Days Ago-0.14-0.47-0.450.21
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesCNATIndustrySectorS&P 500
Current Qtr.51.40%N/AN/A0.22
Next Qtr.-14.30%N/AN/A0.25
Current Year50.40%N/AN/A0.08
Next Year195.40%N/AN/A0.12
Next 5 Years (per annum)38.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A